Portfolio of Renaissance Technologies
Renaissance Technologies was founded by Jim Simons († 2024) and makes investment decisions with mathematical models; the portfolio holds a very large number of stocks.
Source: 13F filing with the US Securities and Exchange Commission dated Aug 12, 2022. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included. Form 13F filingInvestment managers with discretion over at least 100 million USD in reportable US securities (mainly stocks and ETFs, plus options and convertible bonds) report their holdings to the SEC within 45 days after each quarter. Short positions, securities traded only abroad and cash are not included.Example: Positions as of 30 Sep, filed on 14 Nov → they are already six weeks old when published.More in the Academy: Glossary
You are looking at Q2 2022. Go to the latest filing (Q3 2026)
- Total value of stock positions
- 84.5B USD
- Positions
- 4,173
- Share of the ten largest
- 11.0%
The ten largest positions Q2 2022
- Novo Nordisk (ADR) 2.3%▼ −4.6%
- Microsoft 1.2%new
- Meta Platforms 1.0%▲ +82.8%
- Apple Inc. 1.0%▲ +37.2%
- Chevron Corporation 1.0%▲ +600.7%
- Gilead Sciences 1.0%▼ −13.4%
- Kroger 0.9%▲ +1.9%
- Hershey Company (The) 0.9%▲ +20.0%
- Zoom Video Communications In 0.8%▼ −0.3%
- Verisign 0.8%▼ −1.5%
Show all positions of this quarter
Choose a quarter (54 filings)
- Q3 2026
- Q2 2026
- Q1 2026
- Q4 2025
- Q3 2025
- Q2 2025
- Q1 2025
- Q4 2024
- Q3 2024
- Q2 2024
- Q1 2024
- Q4 2023
- Q3 2023
- Q2 2023
- Q1 2023
- Q4 2022
- Q3 2022
- Q2 2022
- Q1 2022
- Q4 2021
- Q3 2021
- Q2 2021
- Q1 2021
- Q4 2020
- Q3 2020
- Q2 2020
- Q1 2020
- Q4 2019
- Q3 2019
- Q2 2019
- Q1 2019
- Q4 2018
- Q3 2018
- Q2 2018
- Q1 2018
- Q4 2017
- Q3 2017
- Q2 2017
- Q1 2017
- Q4 2016
- Q3 2016
- Q2 2016
- Q1 2016
- Q4 2015
- Q3 2015
- Q2 2015
- Q1 2015
- Q4 2014
- Q3 2014
- Q2 2014
- Q1 2014
- Q4 2013
- Q3 2013
- Q2 2013
All positions Q2 2022
| Symbol | Weight | Shares | Reported value | Change | Held since |
|---|---|---|---|---|---|
| NVO Novo Nordisk (ADR) | 2.3% | 17,529,671 | 2.0B USD | −4.6% reduced | Q2 2013 or earlier 37 quarters |
| MSFT Microsoft | 1.2% | 3,820,133 | 981.1M USD | new | Q2 2022 1 quarter |
| META Meta Platforms | 1.0% | 5,485,159 | 884.5M USD | +82.8% increased | Q3 2021 4 quarters |
| AAPL Apple Inc. | 1.0% | 6,179,661 | 844.9M USD | +37.2% increased | Q3 2020 8 quarters |
| CVX Chevron Corporation | 1.0% | 5,786,295 | 837.7M USD | +600.7% increased | Q2 2020 9 quarters |
| GILD Gilead Sciences | 1.0% | 13,409,616 | 828.8M USD | −13.4% reduced | Q4 2014 31 quarters |
| KR Kroger | 0.9% | 16,746,010 | 792.6M USD | +1.9% increased | Q2 2019 13 quarters |
| HSY Hershey Company (The) | 0.9% | 3,671,367 | 789.9M USD | +20.0% increased | Q2 2013 or earlier 37 quarters |
| Zoom Video Communications In | 0.8% | 6,429,004 | 694.1M USD | −0.3% reduced | Q1 2020 10 quarters |
| VRSN Verisign | 0.8% | 3,956,890 | 662.1M USD | −1.5% reduced | Q2 2013 or earlier 37 quarters |
| United Therapeutics Corp Del | 0.8% | 2,793,591 | 658.3M USD | +1.0% increased | Q2 2013 or earlier 37 quarters |
| MRK Merck & Co. | 0.7% | 6,763,934 | 616.7M USD | +32.6% increased | Q2 2019 13 quarters |
| XOM ExxonMobil | 0.7% | 7,156,786 | 612.9M USD | +11.0% increased | Q1 2021 6 quarters |
| Franco Nev Corp | 0.7% | 4,310,103 | 567.1M USD | +5.8% increased | Q1 2014 34 quarters |
| MNST Monster Beverage | 0.6% | 5,655,060 | 524.2M USD | −19.5% reduced | Q1 2014 34 quarters |
| TSLA Tesla, Inc. | 0.6% | 748,475 | 504.0M USD | −51.9% reduced | Q4 2018 15 quarters |
| ABNB Airbnb | 0.6% | 5,604,567 | 499.3M USD | +64.7% increased | Q2 2021 5 quarters |
| VRTX Vertex Pharmaceuticals | 0.6% | 1,761,168 | 496.3M USD | +3.2% increased | Q1 2017 22 quarters |
| BRK-B Berkshire Hathaway | 0.6% | 1,791,000 | 489.0M USD | +2,370.3% increased | Q4 2020 7 quarters |
| Molina Healthcare Inc | 0.6% | 1,719,715 | 480.9M USD | −5.2% reduced | Q2 2013 or earlier 37 quarters |
| HD Home Depot (The) | 0.6% | 1,750,900 | 480.2M USD | −7.0% reduced | Q1 2022 2 quarters |
| ABT Abbott Laboratories | 0.5% | 4,216,503 | 458.1M USD | +34.2% increased | Q3 2021 4 quarters |
| TEAM Atlassian | 0.5% | 2,443,620 | 457.9M USD | −7.6% reduced | Q2 2016 25 quarters |
| PEP PepsiCo | 0.5% | 2,727,014 | 454.5M USD | +39.2% increased | Q1 2021 6 quarters |
| JPM JPMorgan Chase | 0.5% | 3,931,843 | 442.8M USD | +244.8% increased | Q2 2021 5 quarters |
| SHOP Shopify | 0.5% | 14,036,600 | 438.5M USD | new | Q2 2022 1 quarter |
| Gsk PLC | 0.5% | 9,979,321 | 434.4M USD | −0.3% reduced | Q2 2013 or earlier 37 quarters |
| Activision Blizzard Inc | 0.5% | 5,377,098 | 418.7M USD | +52.9% increased | Q1 2022 2 quarters |
| AMD Advanced Micro Devices | 0.5% | 5,320,160 | 406.8M USD | −25.1% reduced | Q1 2022 2 quarters |
| INCY Incyte | 0.5% | 5,142,733 | 390.7M USD | +9.5% increased | Q4 2017 19 quarters |
| CL Colgate-Palmolive | 0.5% | 4,872,486 | 390.5M USD | −14.3% reduced | Q2 2013 or earlier 37 quarters |
| AZN AstraZeneca | 0.5% | 5,859,072 | 387.1M USD | +28.4% increased | Q1 2019 14 quarters |
| NIO NIO | 0.5% | 17,768,900 | 385.9M USD | +229.0% increased | Q2 2021 5 quarters |
| UNP Union Pacific Corporation | 0.5% | 1,785,599 | 380.8M USD | +75.4% increased | Q1 2020 10 quarters |
| RBLX Roblox | 0.5% | 11,580,582 | 380.5M USD | +161.0% increased | Q2 2021 5 quarters |
| AXP American Express | 0.4% | 2,690,194 | 372.9M USD | +5,063.5% increased | Q1 2022 2 quarters |
| Vodafone Group PLC New | 0.4% | 23,913,676 | 372.6M USD | −13.2% reduced | Q3 2015 28 quarters |
| Exelixis Inc | 0.4% | 17,783,937 | 370.3M USD | +5.5% increased | Q3 2016 24 quarters |
| MO Altria | 0.4% | 8,775,416 | 366.5M USD | +132.7% increased | Q2 2019 13 quarters |
| Abiomed Inc | 0.4% | 1,446,523 | 358.0M USD | +2.3% increased | Q1 2015 30 quarters |
| AMGN Amgen | 0.4% | 1,439,745 | 350.3M USD | +279.3% increased | Q3 2021 4 quarters |
| GIS General Mills | 0.4% | 4,575,588 | 345.2M USD | +3.2% increased | Q4 2018 15 quarters |
| REGN Regeneron Pharmaceuticals | 0.4% | 583,062 | 344.7M USD | +108.3% increased | Q3 2021 4 quarters |
| CSX CSX Corporation | 0.4% | 11,529,500 | 335.0M USD | +80.8% increased | Q1 2021 6 quarters |
| Novartis AG | 0.4% | 3,783,370 | 319.8M USD | +11.9% increased | Q3 2013 36 quarters |
| WDAY Workday, Inc. | 0.4% | 2,274,400 | 317.5M USD | +674.2% increased | Q1 2022 2 quarters |
| BIIB Biogen | 0.4% | 1,546,007 | 315.3M USD | +48.1% increased | Q1 2018 18 quarters |
| MRNA Moderna | 0.4% | 2,184,141 | 312.0M USD | −42.8% reduced | Q4 2020 7 quarters |
| Barrick Gold Corp | 0.4% | 17,457,214 | 308.8M USD | +86.6% increased | Q2 2014 33 quarters |
| DPZ Domino's | 0.4% | 791,925 | 308.6M USD | −23.9% reduced | Q2 2013 or earlier 37 quarters |
“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.
Show more (up to 500) Shown: the 50 largest of 4,173 positions.
Breakdown by sector
- Technology 8.1%
- Health Care 7.6%
- Consumer Staples 6.9%
- Consumer Discretionary 4.8%
- Financials 4.6%
- Industrials 4.3%
- Energy 3.3%
- Communication Services 1.7%
- Real Estate 1.7%
- Utilities 1.4%
- Materials 1.0%
- not in our coverage 54.7%
Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.
How to read this page
- Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
- Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
- Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.
All superinvestor portfolios Screener: stocks held by superinvestors